{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:38:02Z","timestamp":1786718282885,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/1673-5374.228713","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:36:02Z","timestamp":1522816562000},"page":"402","source":"Crossref","is-referenced-by-count":9,"title":["The relaxin peptide family \u2013 potential future hope for neuroprotective therapy? A short review"],"prefix":"10.4103","volume":"13","author":[{"given":"Marius","family":"Nistor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Schiffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.228713-1","doi-asserted-by":"crossref","unstructured":"Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ (2013) Relaxin family peptides and their receptors. Physiol Rev 93:405-480.","DOI":"10.1152\/physrev.00001.2012"},{"key":"key-10.4103\/1673-5374.228713-2","doi-asserted-by":"crossref","unstructured":"Bergeron LH, Willcox JM, Alibhai FJ, Connell BJ, Saleh TM, Wilson BC, Summerlee AJ (2015) Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats. Endocrinology 156:638-646.","DOI":"10.1210\/en.2014-1676"},{"key":"key-10.4103\/1673-5374.228713-3","doi-asserted-by":"crossref","unstructured":"Bischoff SJ, Schmidt M, Lehmann T, Irintchev A, Schubert H, Jung C, Schwab M, Huber O, Matziolis G, Schiffner R (2016) Increase of cortical cerebral blood flow and further cerebral microcirculatory effects of Serelaxin in a sheep model. Am J Physiol Heart Circ Physiol 311:H613-620.","DOI":"10.1152\/ajpheart.00118.2016"},{"key":"key-10.4103\/1673-5374.228713-4","doi-asserted-by":"crossref","unstructured":"Callander GE, Bathgate RA (2010) Relaxin family peptide systems and the central nervous system. Cell Mol Life Sci 67:2327-2341.","DOI":"10.1007\/s00018-010-0304-z"},{"key":"key-10.4103\/1673-5374.228713-5","doi-asserted-by":"crossref","unstructured":"Chan SL, Cipolla MJ (2011) Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-\u03b3. FASEB J 25:3229-3239.","DOI":"10.1096\/fj.10-175471"},{"key":"key-10.4103\/1673-5374.228713-6","doi-asserted-by":"crossref","unstructured":"Chan SL, Sweet JG, Cipolla MJ (2013) Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension. FASEB J 27:3917-3927.","DOI":"10.1096\/fj.13-230797"},{"key":"key-10.4103\/1673-5374.228713-7","doi-asserted-by":"crossref","unstructured":"Conrad K1, Shroff SG (2011) Effects of relaxin on arterial dilation, remodeling, and mechanical properties. Curr Hypertens Rep 13:409-420.","DOI":"10.1007\/s11906-011-0231-x"},{"key":"key-10.4103\/1673-5374.228713-8","doi-asserted-by":"crossref","unstructured":"Debrah DO, Novak J, Matthews JE, Ramirez RJ, Shroff SG, Conrad KP (2006) Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 147:5126-5131.","DOI":"10.1210\/en.2006-0567"},{"key":"key-10.4103\/1673-5374.228713-9","doi-asserted-by":"crossref","unstructured":"Ghosh RK, Banerjee K, Tummala R, Ball S, Ravakhah K, Gupta A (2017) Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence. Cardiovasc Ther 35:55-63.","DOI":"10.1111\/1755-5922.12231"},{"key":"key-10.4103\/1673-5374.228713-10","doi-asserted-by":"crossref","unstructured":"Halls ML, Bathgate RA, Sutton SW, Dschietzig TB, Summers RJ (2015) International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. Pharmacol Rev 67:389-440.","DOI":"10.1124\/pr.114.009472"},{"key":"key-10.4103\/1673-5374.228713-11","doi-asserted-by":"crossref","unstructured":"Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV (1998) Outcome after hemorrhagic shock in trauma patients. J Trauma 45:545-549.","DOI":"10.1097\/00005373-199809000-00022"},{"key":"key-10.4103\/1673-5374.228713-12","doi-asserted-by":"crossref","unstructured":"Ma L, Gul R, Habibi J, Yang M, Pulakat L, Whaley-Connell A, Ferrario CM, Sowers JR (2012) Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. Am J Physiol Heart Circ Physiol 302:H2341-2351.","DOI":"10.1152\/ajpheart.01126.2011"},{"key":"key-10.4103\/1673-5374.228713-13","doi-asserted-by":"crossref","unstructured":"Ma S1, Shen PJ, Burazin TC, Tregear GW, Gundlach AL (2006) Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience 141:329-344.","DOI":"10.1016\/j.neuroscience.2006.03.076"},{"key":"key-10.4103\/1673-5374.228713-14","unstructured":"Milia P, Caserio M, Bani D, Rastelli TF, Sonaglia F, Bigazzi B, Bigazzi M (2013) Efficacy of relaxin on functional recovery of post stroke patients. Ital J Anat Embryol 118:S92-97."},{"key":"key-10.4103\/1673-5374.228713-15","doi-asserted-by":"crossref","unstructured":"Nistor M, Behringer W, Schmidt M, Schiffner R (2017) A systematic review of neuroprotective strategies during hypovolemia and hemorrhagic shock. Int J Mol Sci 18:E2247.","DOI":"10.3390\/ijms18112247"},{"key":"key-10.4103\/1673-5374.228713-16","doi-asserted-by":"crossref","unstructured":"No authors listed (2017) Top heart-failure contender serelaxin flops. Nat Biotechnol 35:297.","DOI":"10.1038\/nbt0417-297b"},{"key":"key-10.4103\/1673-5374.228713-17","doi-asserted-by":"crossref","unstructured":"Rickards CA (2015) Cerebral blood-flow regulation during hemorrhage. Compr Physiol 5:1585-1621.","DOI":"10.1002\/cphy.c140058"},{"key":"key-10.4103\/1673-5374.228713-18","doi-asserted-by":"crossref","unstructured":"Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, Wade JD, Craik DJ (2006) Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. J Biol Chem 281:5845-5851.","DOI":"10.1074\/jbc.M511210200"},{"key":"key-10.4103\/1673-5374.228713-19","doi-asserted-by":"crossref","unstructured":"Sarwar M, Du XJ, Dschietzig TB, Summers RJ (2017) The actions of relaxin on the human cardiovascular system. Br J Pharmacol 174:933-949.","DOI":"10.1111\/bph.13523"},{"key":"key-10.4103\/1673-5374.228713-20","doi-asserted-by":"crossref","unstructured":"Wilkinson TN, Speed TP, Tregear GW, Bathgate RA (2005) Evolution of the relaxin-like peptide family. BMC Evol Biol 5:14.","DOI":"10.1186\/1471-2148-5-14"},{"key":"key-10.4103\/1673-5374.228713-21","doi-asserted-by":"crossref","unstructured":"Wilson BC, Milne P, Saleh TM (2005) Relaxin pretreatment decreases infarct size in male rats after middle cerebral artery occlusion. Ann N Y Acad Sci 1041:223-228.","DOI":"10.1196\/annals.1282.035"},{"key":"key-10.4103\/1673-5374.228713-22","doi-asserted-by":"crossref","unstructured":"Wilson BC, Connell B, Saleh TM (2006) Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms. Neurosci Lett 393:160-164.","DOI":"10.1016\/j.neulet.2005.09.059"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:18Z","timestamp":1786714398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.228713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["228713"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.228713","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}